The 157 designation refers to the number of amino acids in the full-length parent protein, not the fragment itself BPC-157 the research peptide is a 15-amino-acid sequence, not 157
As of mid-2024, there are five DOACs approved for use in the United States: Betrixaban (Bevyxxa) Rivaroxaban (Xarelto) Apixaban (Eliquis) Edoxaban (Savaysa) Dabigatran (Pradaxa) The mechanism(s) by which DOACs work differ from those of two other common anticoagulants: Warfarin inhibits clotting by acting as a vitamin K antagonist, and Heparin/low-molecular weight heparin works by activating antithrombin, which inactivates the coagulation enzymes thrombin, factor Xa, and factor IXa
What flavour was the B12 from the doctor
This can be because of high stomach acid or even age
Document the anemia findings in the progress note: Ferritin 11, Hb 9.4 consistent with iron deficiency. Train staff to double-check lab availability before submitting claims
Thats why I say its intriguing. Despite such logical reservations, I asked more than a dozen people I interviewed about side effects and heard only a few anecdotes about minor issues (in one case, stomach problems caused by an athlete screwing up dosages with a mislabeled vial)